Tissue Diagnostic Market Analysis By Product (Instruments, Accessories) By Technology (IHC, Special Staining, In-Situ Hybridization, Digital Pathology & Workflow), By Application (Breast Cancer, Prostate Cancer, Lymphoma Cancer, Gastric Cancer, Non-Small Cell Lung Cancer), By End-use (Hospitals, CRO, Research Laboratories) And Segment Forecasts To 2022

  • Published On: May, 2015
  • No of pages: 84
  • Published by: Grand View Research
  • Format: PDF
Global tissue diagnostic market is expected to reach USD 6.4 billion by 2022. Tissue diagnostic, due to its ability to detect cancer at an early stage, is expected to witness significant growth over the forecast period. Increasing incidences of breast cancer, rising geriatric population base and the growing demand for personalized medicines are high impact rendering drivers of the tissue diagnostics market. Furthermore, improving healthcare infrastructure, increasing demand for safe and cost effective treatment and rising focus of major market players on emerging economies such as India and China are likely to propel market growth. Technological advancement occurring in the field of tissue diagnostics is expected to lead towards the availability of better option for healthcare professionals and the patients. Tissue diagnostic procedures encompass a broad array of technologies designed to revolutionize the cancer diagnosis process and provide apt molecular information. Tissue diagnostic detects the presence of malignant cells by performing microscopic study of the involved tissue. This investigation is considered to be vital for any type of cancer in order to decide the most effective treatment line.

Further key findings from the study suggest:

Immunohistochemistry (IHC) is identified as the most lucrative sub segment of the tissue diagnostic market majorly owing to increasing incidences of cancer diagnostic
The tissue based breast cancer diagnostic segment accounted for the largest market share in 2014. Rising alcohol consumption, lifestyle associated changes and growing geriatric population are some factors expected to drive segment growth over the forecast period.
North America accounted for over 40.0% of the tissue diagnostic market in 2014 on account of high usage rates of technologically advanced products. Rising patient awareness level and the presence of accessible healthcare infrastructure is also expected to contribute towards healthy regional market growth.
Asia Pacific is expected to witness the fastest growth over the forecast period. Rapid economic development and the consequent improvement of the healthcare infrastructure is expected to help manufacturers capitalize on the available opportunities in the form of unmet medical needs. Presence of sophisticated healthcare facilities in the developed markets of Japan and Australia is also expected to boost usage rates over the forecast period.
Key players of the tissue diagnostic market include Roche Diagnostics, Cell Signaling Technologies, Becton Dickinson & Company, Agilent Technologies, Abbott Laboratories, GE Healthcare, Thermo Fisher Scientific, Johnson & Johnson and Danaher Corporation.
For the purpose of this study, Grand View Research has segmented the global tissue diagnostic market on the basis of products, technology, application, end-use and region:

Global Tissue Diagnostic Product Outlook (Revenue, USD Million, 2012 - 2022)

Instruments
Accessories
Global Tissue Diagnostic Technology Outlook (Revenue, USD Million, 2012 - 2022)

Immunohistochemistry (IHC)
In Situ Hybridization
Special Staining
Digital Pathology and Workflow
Global Tissue Diagnostic Application Outlook (Revenue, USD Million, 2012 - 2022)

Lymphoma
Breast Cancer
Gastric Cancer
Prostate Cancer
Non Small Cell Lung Cancer
Global Tissue Diagnostic End-use Outlook (Revenue, USD Million, 2012 - 2022)

Hospitals
Contract Research Organization (CRO)
Pharmaceutical Organizations
Research Laboratories
Tissue Diagnostic Regional Outlook (Revenue, USD Million, 2012 - 2022)

North America
U.S.
Canada
Rest of North America
Europe
Germany
France
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa (MEA)
South Africa
Rest of Middle East and Africa
Table of Contents
Chapter 1. Methodology and Scope 1.1. Research methodology 1.2. Research scope & assumption 1.3. List of data sources Chapter 2. Executive Summary 2.1. Tissue Diagnostic Market - Industry Summary and Key Buying Criteria, 2012 - 2022 Chapter 3. Tissue Diagnostic Industry Outlook 3.1. Tissue Diagnostic Market Segmentation 3.2. Tissue Diagnostic Market Size And Growth Prospects 3.3. Tissue Diagnostic Market Dynamics 3.3.1. Market Driver Analysis 3.3.2. Market Restraint Analysis 3.4. Key Opportunities Prioritized 3.5. Industry analysis - Porter's 3.6. Tissue Diagnostic Market PESTEL Analysis, 2014 Chapter 4. Tissue Diagnostic Market Product Outlook 4.1. Tissue Diagnostic Market Share By Product, 2014 & 2022 4.2. Instruments Market Estimates And Forecasts, 2012 - 2022 (USD Million) 4.3. Accessories Market Estimates And Forecasts, 2012 - 2022 (USD Million) Chapter 5. Tissue Diagnostic Market Technology Outlook 5.1. Tissue Diagnostic Market Share By Technology, 2014 & 2022 5.2. Immunohistochemistry (IHC) Market Estimates And Forecasts, 2012 - 2022 (USD Million) 5.3. In situ Hybridization Market Estimates And Forecasts, 2012 - 2022 (USD Million) 5.4. Special Staining Market Estimates And Forecasts, 2012 - 2022 (USD Million) 5.5. Digital Pathology & Workflow Market Estimates And Forecasts, 2012 - 2022 (USD Million) Chapter 6. Tissue Diagnostic Market Application Outlook 6.1. Tissue Diagnostic Market Share By Application, 2014 & 2022 6.2. Lymphoma Market Estimates And Forecasts, 2012 - 2022 (USD Million) 6.3. Breast Cancer Market Estimates And Forecasts, 2012 - 2022 (USD Million) 6.4. Gastric Cancer Market Estimates And Forecasts, 2012 - 2022 (USD Million) 6.5. Prostate Cancer Market Estimates And Forecasts, 2012 - 2022 (USD Million) 6.6. Non small Cell Lung Cancer Market Estimates And Forecasts, 2012 - 2022 (USD Million) Chapter 7. Tissue Diagnostic Market End-Use Outlook 7.1. Tissue Diagnostic Market Share By End-Use, 2014 & 2022 7.2. Hospitals Market Estimates And Forecasts, 2012 - 2022 (USD Million) 7.3. Contract Research Organization (CRO) Market Estimates And Forecasts, 2012 - 2022 (USD Million) 7.4. Pharmaceutical Organization Market Estimates And Forecasts, 2012 - 2022 (USD Million) 7.5. Research Laboratories Market Estimates And Forecasts, 2012 - 2022 (USD Million) Chapter 8. Tissue Diagnostic Market Regional Outlook 8.1. North America 8.1.1. North America Tissue Diagnostic Market Estimates And Forecasts, By Product, 2012 - 2022 (USD Million) 8.1.2. North America Tissue Diagnostic Market Estimates And Forecasts, By Technology, 2012 - 2022 (USD Million) 8.1.3. North America Tissue Diagnostic Market Estimates And Forecasts, By Application, 2012 - 2022 (USD Million) 8.1.4. North America Tissue Diagnostic Market Estimates And Forecasts, By End-Use, 2012 - 2022 (USD Million) 8.1.4.1. U.S. Market Estimates And Forecasts 8.1.4.2. Canada Market Estimates And Forecasts 8.2. Europe 8.2.1. Europe Tissue Diagnostic Market Estimates And Forecasts, By Product, 2012 - 2022 (USD Million) 8.2.2. Europe Tissue Diagnostic Market Estimates And Forecasts, By Technology, 2012 - 2022 (USD Million) 8.2.3. Europe Tissue Diagnostic Market Estimates And Forecasts, By Application, 2012 - 2022 (USD Million) 8.2.4. Europe Tissue Diagnostic Market Estimates And Forecasts, By End-Use, 2012 - 2022 (USD Million) 8.2.4.1. Spain Market Estimates And Forecasts 8.2.4.2. Germany Market Estimates And Forecasts 8.2.4.3. France Market Estimates And Forecasts 8.3. Asia Pacific 8.3.1. Asia Pacific Tissue Diagnostic Market Estimates And Forecasts, By Product, 2012 - 2022 (USD Million) 8.3.2. Asia Pacific Tissue Diagnostic Market Estimates And Forecasts, By Technology, 2012 - 2022 (USD Million) 8.3.3. Asia Pacific Tissue Diagnostic Market Estimates And Forecasts, By Application, 2012 - 2022 (USD Million) 8.3.4. Asia Pacific Tissue Diagnostic Market Estimates And Forecasts, By End-Use, 2012 - 2022 (USD Million) 8.3.4.1. India Market Estimates And Forecasts 8.3.4.2. China Market Estimates And Forecasts 8.3.4.3. Japan Market Estimates And Forecasts 8.4. Latin America 8.4.1. Latin America Tissue Diagnostic Market Estimates And Forecasts, By Product, 2012 - 2022 (USD Million) 8.4.2. Latin America Tissue Diagnostic Market Estimates And Forecasts, By Technology, 2012 - 2022 (USD Million) 8.4.3. Latin America Tissue Diagnostic Market Estimates And Forecasts, By Application, 2012 - 2022 (USD Million) 8.4.4. Latin America Tissue Diagnostic Market Estimates And Forecasts, By End-Use, 2012 - 2022 (USD Million) 8.4.4.1. Mexico market estimates and forecasts 8.4.4.2. Brazil market estimates and forecasts 8.5. MEA 8.5.1. MEA Tissue Diagnostic Market Estimates And Forecasts, By Product, 2012 - 2022 (USD Million) 8.5.2. MEA Tissue Diagnostic Market Estimates And Forecasts, By Technology, 2012 - 2022 (USD Million) 8.5.3. MEA Tissue Diagnostic Market Estimates And Forecasts, By Application, 2012 - 2022 (USD Million) 8.5.4. MEA Tissue Diagnostic Market Estimates And Forecasts, By End-Use, 2012 - 2022 (USD Million) 8.5.4.1. South Africa Market Estimates And Forecasts Chapter 9. Competitive Landscape 9.1. Roche Diagnostics 9.1.1. Company Overview 9.1.2. Financial Performance 9.1.3. Product Benchmarking 9.1.4. Strategic Initiatives 9.2. Agilent Technologies 9.2.1. Company Overview 9.2.2. Financial Performance 9.2.3. Product Benchmarking 9.2.4. Strategic Initiatives 9.3. BioGenex Laboratories 9.3.1. Company Overview 9.3.2. Financial Performance 9.3.3. Product Benchmarking 9.3.4. Strategic Initiatives 9.4. Cell Signaling Technologies 9.4.1. Company Overview 9.4.2. Financial Performance 9.4.3. Product Benchmarking 9.4.4. Strategic Initiatives 9.5. Abbott Laboratories 9.5.1. Company Overview 9.5.2. Financial Performance 9.5.3. Product Benchmarking 9.5.4. Strategic Initiatives 9.6. Life Technologies 9.6.1. Company Overview 9.6.2. Financial Performance 9.6.3. Product Benchmarking 9.6.4. Strategic Initiatives 9.7. Sigma Aldrich 9.7.1. Company Overview 9.7.2. Financial Performance 9.7.3. Product Benchmarking 9.7.4. Strategic Initiatives 9.8. Danaher Corporation 9.8.1. Company Overview 9.8.2. Financial Performance 9.8.3. Product Benchmarking 9.8.4. Strategic Initiatives 9.9. Thermo Fisher Scientific 9.9.1. Company Overview 9.9.2. Financial Performance 9.9.3. Product Benchmarking 9.9.4. Strategic Initiatives 9.10. Bio SB 9.10.1. Company Overview 9.10.2. Financial Performance 9.10.3. Product Benchmarking 9.10.4. Strategic Initiatives 9.11. GE Healthcare 9.11.1. Company Overview 9.11.2. Financial Performance 9.11.3. Product Benchmarking 9.11.4. Strategic Initiatives 9.12. Johnson & Johnson 9.12.1. Company Overview 9.12.2. Financial Performance 9.12.3. Product Benchmarking 9.12.4. Strategic Initiatives 9.13. Siemens Healthcare 9.13.1. Company Overview 9.13.2. Financial Performance 9.13.3. Product Benchmarking 9.13.4. Strategic Initiatives 9.14. Qiagen 9.14.1. Company Overview 9.14.2. Financial Performance 9.14.3. Product Benchmarking 9.14.4. Strategic Initiatives 9.15. Becton Dickinson & Company 9.15.1. Company Overview 9.15.2. Financial Performance 9.15.3. Product Benchmarking 9.15.4. Strategic Initiatives 9.16. Alere 9.16.1. Company Overview 9.16.2. Financial Performance 9.16.3. Product Benchmarking 9.16.4. Strategic Initiatives 9.17. DiaGenic 9.17.1. Company Overview 9.17.2. Financial Performance 9.17.3. Product Benchmarking 9.17.4. Strategic Initiatives 9.18. bioMerieux 9.18.1. Company Overview 9.18.2. Financial Performance 9.18.3. Product Benchmarking 9.18.4. Strategic Initiatives 9.19. Prometheus Laboratories 9.19.1. Company Overview 9.19.2. Financial Performance 9.19.3. Product Benchmarking 9.19.4. Strategic Initiatives List of Tables 1. Tissue Diagnostic Market - Industry Summary 2. Tissue Diagnostic Market, by Product, (USD million), 2012 - 2022 3. Tissue Diagnostic Market, by Technology, (USD million), 2012 - 2022 4. Tissue Diagnostic Market, by Application, (USD million), 2012 - 2022 5. Tissue Diagnostic Market, by End-Use, (USD million), 2012 - 2022 6. Tissue Diagnostic Market, by Region, (USD million), 2012 - 2022 7. Tissue Diagnostic Market - Key Market Drivers Analysis 8. Tissue Diagnostic Market - Key Market Restraints Analysis 9. North America Market, by Product, (USD million), 2012 - 2022 10. North America Market, by Technology, (USD million), 2012 - 2022 11. North America Market, by Application, (USD million), 2012 - 2022 12. North America Market, by End-Use, (USD million), 2012 - 2022 13. U.S. Market, by Product, (USD million), 2012 - 2022 14. U.S. Market, by Technology, (USD million), 2012 - 2022 15. U.S. Market, by Application, (USD million), 2012 - 2022 16. U.S. Market, by End-Use, (USD million), 2012 - 2022 17. Europe Market, by Product, (USD million), 2012 - 2022 18. Europe Market, by Technology, (USD million), 2012 - 2022 19. Europe Market, by Application, (USD million), 2012 - 2022 20. Europe Market, by End-Use, (USD million), 2012 - 2022 21. Germany Market, by Product, (USD million), 2012 - 2022 22. Germany Market, by Technology, (USD million), 2012 - 2022 23. Germany Market, by Application, (USD million), 2012 - 2022 24. Germany Market, by End-Use, (USD million), 2012 - 2022 25. France Market, by Product, (USD million), 2012 - 2022 26. France Market, by Technology, (USD million), 2012 - 2022 27. France Market, by Application, (USD million), 2012 - 2022 28. France Market, by End-Use, (USD million), 2012 - 2022 29. Spain Market, by Product, (USD million), 2012 - 2022 30. Spain Market, by Technology, (USD million), 2012 - 2022 31. Spain Market, by Application, (USD million), 2012 - 2022 32. Spain Market, by End-Use, (USD million), 2012 - 2022 33. Asia Pacific Market, by Product, (USD million), 2012 - 2022 34. Asia Pacific Market, by Technology, (USD million), 2012 - 2022 35. Asia Pacific Market, by Application, (USD million), 2012 - 2022 36. Asia Pacific Market, by End-Use, (USD million), 2012 - 2022 37. Japan Market, by Product, (USD million), 2012 - 2022 38. Japan Market, by Technology, (USD million), 2012 - 2022 39. Japan Market, by Application, (USD million), 2012 - 2022 40. Japan Market, by End-Use, (USD million), 2012 - 2022 41. China Market, by Product, (USD million), 2012 - 2022 42. China Market, by Technology, (USD million), 2012 - 2022 43. China Market, by Application, (USD million), 2012 - 2022 44. China Market, by End-Use, (USD million), 2012 - 2022 45. India Market, by Product, (USD million), 2012 - 2022 46. India Market, by Technology, (USD million), 2012 - 2022 47. India Market, by Application, (USD million), 2012 - 2022 48. India Market, by End-Use, (USD million), 2012 - 2022 49. Latin America Market, by Product, (USD million), 2012 - 2022 50. Latin America Market, by Technology, (USD million), 2012 - 2022 51. Latin America Market, by Application, (USD million), 2012 - 2022 52. Latin America Market, by End-Use, (USD million), 2012 - 2022 53. Mexico Market, by Product, (USD million), 2012 - 2022 54. Mexico Market, by Technology, (USD million), 2012 - 2022 55. Mexico Market, by Application, (USD million), 2012 - 2022 56. Mexico Market, by End-Use, (USD million), 2012 - 2022 57. Brazil Market, by Product, (USD million), 2012 - 2022 58. Brazil Market, by Technology, (USD million), 2012 - 2022 59. Brazil Market, by Application, (USD million), 2012 - 2022 60. Brazil Market, by End-Use, (USD million), 2012 - 2022 61. Middle East and Africa (MEA) Market, by Product, (USD million), 2012 - 2022 62. Middle East and Africa (MEA) Market, by Technology, (USD million), 2012 - 2022 63. Middle East and Africa (MEA) Market, by Application, (USD million), 2012 - 2022 64. Middle East and Africa (MEA) Market, by End-Use, (USD million), 2012 - 2022 65. South Africa Market, by Product, (USD million), 2012 - 2022 66. South Africa Market, by Technology, (USD million), 2012 - 2022 67. South Africa Market, by Application, (USD million), 2012 - 2022 68. South Africa Market, by End-Use, (USD million), 2012 - 2022 List of Figures 1. Tissue Diagnostic Market Segmentation 2. Global Tissue Diagnostic Market Revenue, 2012 - 2022 3. Tissue Diagnostic Market Dynamics 4. Key Opportunities Prioritized 5. Tissue Diagnostic Market Analysis - Porter's 6. Tissue Diagnostic Market Analysis - PESTEL Analysis 7. Global Tissue Diagnostic Market , By Product, (USD million), 2012 - 2022 8. Instruments Market, (USD million), 2012 - 2022 9. Accessories Market, (USD million), 2012 - 2022 10. Global Tissue Diagnostic Market , By Technology, (USD million), 2012 - 2022 11. Immunohistochemistry (IHC) Market, 2012 to 2022 (USD million) 12. In Situ Hybridization Market, 2012 to 2022 (USD million) 13. Special Staining Market, 2012 to 2022 (USD million) 14. Digital Pathology and Workflow Market 2012 to 2022 (USD million) 15. Global Tissue Diagnostic Market, By Application 2012 to 2022 (USD million) 16. Lymphoma Market, 2012 to 2022 (USD million) 17. Breast Cancer Market, 2012 to 2022 (USD million) 18. Gastric Cancer Market, 2012 to 2022(USD million) 19. Prostate Market, 2012 to 2022 (USD million) 20. Non Small Cell Lung Cancer Market, 2012 to 2022 (USD million) 21. Global Tissue Diagnostic Market, By End-Use 2012 to 2022 (USD million) 22. Hospital Market, 2012 to 2022 (USD million) 23. Contract Research Organization (CRO) Market, 2012 to 2022 (USD million) 24. Pharmaceutical Organization Market, 2012 to 2020 (USD million) 25. Research Laboratories Market, 2012 to 2020 (USD million) 26. Global Tissue Diagnostic Market, By Region 2012 to 2022 (USD million) 27. North America Market, by Product, 2012 to 2022 (USD million) 28. North America Market, by Technology, 2012 to 2022 (USD million) 29. North America Market, by Application, 2012 to 2022 (USD million) 30. North America Market, by End-Use, 2012 to 2022 (USD million) 31. U.S. Market, by Product, 2012 to 2022 (USD million) 32. U.S. Market, by Technology, 2012 to 2022 (USD million) 33. U.S. Market, by Application, 2012 to 2022 (USD million) 34. U.S. Market, by End-Use, 2012 to 2022 (USD million) 35. Canada Market, by Product, 2012 to 2022 (USD million) 36. Canada Market, by Technology, 2012 to 2022 (USD million) 37. Canada Market, by Application, 2012 to 2022 (USD million) 38. Canada Market, by End-Use, 2012 to 2022 (USD million) 39. Europe Market, by Product, 2012 to 2022 (USD million) 40. Europe Market, by Technology, 2012 to 2022 (USD million) 41. Europe Market, by Application, 2012 to 2022 (USD million) 42. Europe Market, by End-Use, 2012 to 2022 (USD million) 43. Germany Market, by Product, 2012 to 2022 (USD million) 44. Germany Market, by Technology, 2012 to 2022 (USD million) 45. Germany Market, by Application, 2012 to 2022 (USD million) 46. Germany Market, by End-Use, 2012 to 2022 (USD million) 47. France Market, by Product, 2012 to 2022 (USD million) 48. France Market, by Technology, 2012 to 2022 (USD million) 49. France Market, by Application, 2012 to 2022 (USD million) 50. France Market, by End-Use, 2012 to 2022 (USD million) 51. Spain Market, by Product, 2012 to 2022 (USD million) 52. Spain Market, by Technology, 2012 to 2022 (USD million) 53. Spain Market, by Application, 2012 to 2022 (USD million) 54. Spain Market, by End-Use, 2012 to 2022 (USD million) 55. Asia Pacific Market, by Product, 2012 to 2022 (USD million) 56. Asia Pacific Market, by Technology, 2012 to 2022 (USD million) 57. Asia Pacific Market, by Application, 2012 to 2022 (USD million) 58. Asia Pacific Market, by End-Use, 2012 to 2022 (USD million) 59. Japan Market, by Product, 2012 to 2022 (USD million) 60. Japan Market, by Technology, 2012 to 2022 (USD million) 61. Japan Market, by Application, 2012 to 2022 (USD million) 62. Japan Market, by End-Use, 2012 to 2022 (USD million 63. China Market, by Product, 2012 to 2022 (USD million) 64. China Market, by Technology, 2012 to 2022 (USD million) 65. China Market, by Application, 2012 to 2022 (USD million) 66. China Market, by End-Use, 2012 to 2022 (USD million 67. India Market, by Product, 2012 to 2022 (USD million) 68. India Market, by Technology, 2012 to 2022 (USD million) 69. India Market, by Application, 2012 to 2022 (USD million) 70. India Market, by End-Use, 2012 to 2022 (USD million) 71. Latin America Market, by Product, 2012 to 2022 (USD million) 72. Latin America Market, by Technology, 2012 to 2022 (USD million) 73. Latin America Market, by Application, 2012 to 2022 (USD million) 74. Latin America Market, by End-Use, 2012 to 2022 (USD million) 75. Brazil Market, by Product, 2012 to 2022 (USD million) 76. Brazil Market, by Technology, 2012 to 2022 (USD million) 77. Brazil Market, by Application, 2012 to 2022 (USD million) 78. Brazil Market, by End-Use, 2012 to 2022 (USD million) 79. Mexico Market, by Product, 2012 to 2022 (USD million) 80. Mexico Market, by Technology, 2012 to 2022 (USD million) 81. Mexico Market, by Application, 2012 to 2022 (USD million) 82. Mexico Market, by End-Use, 2012 to 2022 (USD million) 83. MEA Market, by Product, 2012 to 2022 (USD million) 84. MEA Market, by Technology, 2012 to 2022 (USD million) 85. MEA Market, by Application, 2012 to 2022 (USD million) 86. MEA Market, by End-Use, 2012 to 2022 (USD million) 87. South Africa Market, by Product, 2012 to 2022 (USD million) 88. South Africa Market, by Technology, 2012 to 2022 (USD million) 89. South Africa Market, by Application, 2012 to 2022 (USD million) 90. South Africa Market, by End-Use, 2012 to 2022 (USD million)